NCT00036114

Brief Summary

The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Mar 2000

Typical duration for phase_3 alzheimer-disease

Geographic Reach
1 country

41 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2000

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

May 7, 2002

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 9, 2002

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2003

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2003

Completed
Last Updated

November 11, 2013

Status Verified

April 1, 2011

Enrollment Period

3.4 years

First QC Date

May 7, 2002

Last Update Submit

November 7, 2013

Conditions

Alzheimer Disease

Keywords

Psychosis associated with dementia of the Alzheimer's type

Interventions

aripiprazoleDRUG

Eligibility Criteria

Age55 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Institutionalized patients with Alzheimer's

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (41)

Local Institution

Tuscaloosa, Alabama, United States

Location

Local Institution

Scottsdale, Arizona, United States

Location

Local Institution

Cerritos, California, United States

Location

Local Institution

Granada Hills, California, United States

Location

Local Institution

Los Angeles, California, United States

Location

Local Institution

San Diego, California, United States

Location

Local Institution

Torrance, California, United States

Location

Local Institution

Denver, Colorado, United States

Location

Local Institution

Hamden, Connecticut, United States

Location

Local Institution

Miami, Florida, United States

Location

Local Institution

North Miami Beach, Florida, United States

Location

Local Institution

West Palm Beach, Florida, United States

Location

Local Institution

Atlanta, Georgia, United States

Location

Local Institution

Augusta, Georgia, United States

Location

Local Institution

Macon, Georgia, United States

Location

Local Institution

Honolulu, Hawaii, United States

Location

Local Institution

North Chicago, Illinois, United States

Location

Local Institution

Springfield, Illinois, United States

Location

Local Institution

New Orleans, Louisiana, United States

Location

Local Institution

Shreveport, Louisiana, United States

Location

Local Institution

Baltimore, Maryland, United States

Location

Local Institution

Newton Center, Massachusetts, United States

Location

Local Institution

Springfield, Massachusetts, United States

Location

Local Institution

Wellesley Hills, Massachusetts, United States

Location

Local Institution

Lyons, New Jersey, United States

Location

Local Institution

Albany, New York, United States

Location

Local Institution

Lawrence, New York, United States

Location

Local Institution

Montrose, New York, United States

Location

Local Institution

Northport, New York, United States

Location

Local Institution

White Plains, New York, United States

Location

Local Institution

Raleigh, North Carolina, United States

Location

Local Institution

Beachwood, Ohio, United States

Location

Local Institution

Portland, Oregon, United States

Location

Local Institution

Hershey, Pennsylvania, United States

Location

Local Institution

Austin, Texas, United States

Location

Local Institution

Dallas, Texas, United States

Location

Local Institution

San Antonio, Texas, United States

Location

Local Institution

Wichita Falls, Texas, United States

Location

Local Institution

Bennington, Vermont, United States

Location

Local Institution

Charlottesville, Virginia, United States

Location

Local Institution

Seattle, Washington, United States

Location

Related Publications (1)

  • Muhlbauer V, Mohler R, Dichter MN, Zuidema SU, Kopke S, Luijendijk HJ. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia. Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.

    PMID: 34918337DERIVED

MeSH Terms

Conditions

Alzheimer Disease

Interventions

Aripiprazole

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

PiperazinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsQuinolonesQuinolinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Design

Study Type
interventional
Phase
phase 3
Purpose
TREATMENT
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

May 7, 2002

First Posted

May 9, 2002

Study Start

March 1, 2000

Primary Completion

August 1, 2003

Study Completion

August 1, 2003

Last Updated

November 11, 2013

Record last verified: 2011-04

Locations

US(41)